This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleeff, J. Articles by Korc, M. Search for Related Content PubMed PubMed Citation Articles by Kleeff, J. Articles by Korc, M.

The Helix-Loop-Helix Protein Id2 Is Overexpressed in Human Pancreatic Cancer¹

Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, California 92697 [J. K., T. I., M. K.]; Department of Visceral and Transplantation Surgery, University of Bern, 3010 Bern, Switzerland [H. F., M. W. B.]; and Preuss Laboratory, Department of Neurological Surgery, University of California, San Francisco, California 94143 [M. A. I.]

Id2 belongs to the Id family of helix-loop-helix (HLH) proteins, which upon heterodimerization with basic HLH proteins prevent basic HLH proteins from DNA binding. Proteins of the Id family act as negative regulatory transcriptional factors, and their expression correlates with cell proliferation and arrested differentiation in many cell lineages. In this study, we characterized the expression of Id2 in normal and cancerous pancreatic tissues. Pancreatic cancers markedly overexpressed Id2 mRNA in comparison to the normal pancreas. Furthermore, there was abundant Id2 immunoreactivity in the cancer cells within the pancreatic tumor mass. In PANC-1 human pancreatic cancer cells, steady-state Id2 mRNA levels increased upon serum addition and decreased after induction of differentiation with either sodium butyrate or 12-O-tetradecanoylphorbol-13-acetate. Inhibition of Id2 expression with Id2 antisense oligonucleotides inhibited the growth of these cells, whereas random and sense oligonucleotides were without effect. These findings suggest that Id2 may have a role in human pancreatic cancer.

¹ This work was supported by USPHS Grants CA-40162 (to M. K.). J. K. was the recipient of a fellowship award from the University of California Research and Education Grant on Gene Therapy for Cancer.

² To whom requests for reprints should be addressed, at Division of Endocrinology, Diabetes and Metabolism, Medical Sciences I, C240, University of California, Irvine, CA 92697. Phone: (714) 824-6887; Fax: (714) 824-1035.

Received 6/19/98. Accepted 7/17/98.

This article has been cited by other articles:

				V. A. Trabosh, K. A. Divito, B. D. Aguda, C. M. Simbulan-Rosenthal, and D. S. Rosenthal Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis Carcinogenesis, July 1, 2009; 30(7): 1252 - 1259. [Abstract] [Full Text] [PDF]

				T. K. Lee, R. T.P. Poon, A. P. Yuen, M. T. Ling, X. H. Wang, Y. C. Wong, X. Y. Guan, K. Man, Z. Y. Tang, and S. T. Fan Regulation of Angiogenesis by Id-1 through Hypoxia-Inducible Factor-1{alpha}-Mediated Vascular Endothelial Growth Factor Up-regulation in Hepatocellular Carcinoma Clin. Cancer Res., December 1, 2006; 12(23): 6910 - 6919. [Abstract] [Full Text] [PDF]

				N. Umetani, H. Takeuchi, A. Fujimoto, M. Shinozaki, A. J. Bilchik, and D. S. B. Hoon Epigenetic Inactivation of ID4 in Colorectal Carcinomas Correlates with Poor Differentiation and Unfavorable Prognosis Clin. Cancer Res., November 15, 2004; 10(22): 7475 - 7483. [Abstract] [Full Text] [PDF]

				M.-T. Ling, X. Wang, D. T. Lee, P.C. Tam, S.-W. Tsao, and Y.-C. Wong Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R) Carcinogenesis, April 1, 2004; 25(4): 517 - 525. [Abstract] [Full Text] [PDF]

				J.-P. Coppe, Y. Itahana, D. H. Moore, J. L. Bennington, and P.-Y. Desprez Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression Clin. Cancer Res., March 15, 2004; 10(6): 2044 - 2051. [Abstract] [Full Text] [PDF]

				T. K.-W. Lee, K. Man, M.-T. Ling, X.-H. Wang, Y.-C. Wong, C.-M. Lo, R. T.-P. Poon, I. O.-L. Ng, and S.-T. Fan Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway Carcinogenesis, November 1, 2003; 24(11): 1729 - 1736. [Abstract] [Full Text] [PDF]

				T. G. Shepherd and M. W. Nachtigal Identification of a Putative Autocrine Bone Morphogenetic Protein-Signaling Pathway in Human Ovarian Surface Epithelium and Ovarian Cancer Cells Endocrinology, August 1, 2003; 144(8): 3306 - 3314. [Abstract] [Full Text] [PDF]

				L. R. Howe, O. Watanabe, J. Leonard, and A. M. C. Brown Twist Is Up-Regulated in Response to Wnt1 and Inhibits Mouse Mammary Cell Differentiation Cancer Res., April 15, 2003; 63(8): 1906 - 1913. [Abstract] [Full Text] [PDF]

				C.-j. Liu, B. Ding, H. Wang, and P. Lengyel The MyoD-Inducible p204 Protein Overcomes the Inhibition of Myoblast Differentiation by Id Proteins Mol. Cell. Biol., May 1, 2002; 22(9): 2893 - 2905. [Abstract] [Full Text] [PDF]

				X. S. Ouyang, X. Wang, M.-T. Ling, H. L. Wong, S. W. Tsao, and Y.C. Wong Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16INK4a/pRB pathway Carcinogenesis, May 1, 2002; 23(5): 721 - 725. [Abstract] [Full Text] [PDF]

				J. W. Wilson, R. W. Deed, T. Inoue, M. Balzi, A. Becciolini, P. Faraoni, C. S. Potten, and J. D. Norton Expression of Id Helix-Loop-Helix Proteins in Colorectal Adenocarcinoma Correlates with p53 Expression and Mitotic Index Cancer Res., December 1, 2001; 61(24): 8803 - 8810. [Abstract] [Full Text] [PDF]

				M. E. Massari and C. Murre Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms Mol. Cell. Biol., January 15, 2000; 20(2): 429 - 440. [Full Text]

				J. Norton ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis J. Cell Sci., January 11, 2000; 113(22): 3897 - 3905. [Abstract] [PDF]

				H. Maruyama, J. Kleeff, S. Wildi, H. Friess, M. W. Buchler, M. A. Israel, and M. Korc Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis Am. J. Pathol., September 1, 1999; 155(3): 815 - 822. [Abstract] [Full Text] [PDF]

				S. P. Rockman, S. A. Currie, M. Ciavarella, E. Vincan, C. Dow, R. J. S. Thomas, and W. A. Phillips Id2 Is a Target of the beta -Catenin/T Cell Factor Pathway in Colon Carcinoma J. Biol. Chem., November 21, 2001; 276(48): 45113 - 45119. [Abstract] [Full Text] [PDF]